期刊文献+

重症药疹45例临床分析 被引量:22

A Clinical Analysis of 45 Cases with Severe Drug Eruption
下载PDF
导出
摘要 目的探讨重症药疹的发病特点、临床特征及预后的相关因素。方法对本科1996年7月-2010年3月收治的45例重症药疹患者的临床资料进行回顾性分析。结果致敏药物以抗生素最为常见,其次为解热镇痛药,中药过敏者数量多于以往文献报道;别嘌醇所致药疹潜伏期长,重症多形性红斑型为最常见的重症药疹。死亡3例,死因主要为感染和脏器衰竭。结论早期足量使用糖皮质激素有助于病情的控制,联用人免疫球蛋白对危重患者有效;预后与年龄、皮损范围、糖皮质激素的应用、有无继发感染和基础疾病及严重程度密切相关。 Objective To explore the occurrence regularity, clinical manifestation, diagnosis, treatment experience and prognosis of severe drug eruption(SDE). Methods A retrospective analysis was carried out on the clinical data of 45 patients suffered from drug eruption and admitted to our hospital from 1996 to 2010. Results Antibiotics and nonsteroidal anti-inflammatory drugs were the most common causative drugs, the number of allergies to Chinese traditional medicine was larger than the previous reports, allopurinol-induced severe drug eruption had longer latent period, erythema multiforme major was the most common pattern. Three cases died of pulmonary infection and multiple organ failure. Conclusion It is important to give sufficient corticosteroid treatment in early stage. Intravenous immunoglobulin combined with cortieosteroid was a good treatment option for some severe eases. It is suggested that the prognosis of SDE is determined by multi-factors such as patient' s age, lesion area, the dosage of systemic corticosteroid, pulmonary infection and systemic diseases and so on.
作者 王莉 赵俊英
出处 《中国皮肤性病学杂志》 CAS 北大核心 2012年第10期904-906,共3页 The Chinese Journal of Dermatovenereology
关键词 重症药疹 临床分析 Severe drug eruption Clinical manifestation
  • 相关文献

参考文献9

  • 1Mockenhanpt M, Viboud C, Dunant A, et al. Stevens-Johnson syn- drome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study[ J ]. J Invest Dermatol, 2008,128 ( 1 ) :35 - 44. 被引量:1
  • 2张学军.皮肤性病学[M].6版.北京:人民卫生出版社.2005:164. 被引量:61
  • 3刘锡钧主编..实用药物指南[M].北京:人民军医出版社,2000:849.
  • 4许建明.急性药物性肝损伤诊治建议(草案)[J].中华消化杂志,2007,27(11):765-767. 被引量:349
  • 5汪小柳,李锐,方红,郭田章.38例重症药疹临床分析[J].实用皮肤病学杂志,2010,3(3):137-140. 被引量:15
  • 6Roujeau JC. Toxic epidermal neerolysis and Steven-Johnson syndrome. [ J ]. Rev Prat,2007,57 ( 11 ) : 1165 - 1170. 被引量:1
  • 7Hanken I, Schimmer M, Sander CA. Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis [ J ]. J Dtsch Dermatol Ges,2010,8 (5) :341 - 346. 被引量:1
  • 8Trent JT, I-Ialem M, French LE, et al. Toxic epidermal necrolysis and intravenous i mmunoglobulin : A review[ J ]. Seminars in cutaneous med- icine and surgery,2006,25 (2) : 91 -93. 被引量:1
  • 9Chang HL, Tang CH, Hsu YM, et al. Nosocomial outbreak of infection with muhidrug-resistant Acinetobacter baumanii in a medical center in Taiwan[ J]. Infect Control Hosp Epidemio1,2009,30( 1 ) :34 - 38. 被引量:1

二级参考文献16

  • 1Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis, 2002, 22: 145-155. 被引量:1
  • 2Amacher DE. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol, 1998, 27:119-130. 被引量:1
  • 3Andrade RJ, Lucena MI, Pachkoria K, et al. Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI). J Hepatol, 2006, 44(suppl 2):S247. 被引量:1
  • 4Nathwani RA, Kaplowitz N. Drug hepatotoxicity. Clin Liver Dis, 2006, 10:207-217. 被引量:1
  • 5Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11 : 272-276 被引量:1
  • 6Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf, 2007, 30:277-294. 被引量:1
  • 7Temple R. Hy's law: predicting serious hepatotoxicity. Pharmaco epidemiol Drug Saf, 2006, 15 : 241-243. 被引量:1
  • 8Poison J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology, 2005, 41 : 1179-1197. 被引量:1
  • 9Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med, 2006, 354:731-739. 被引量:1
  • 10Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol, 2000, 33:949-952. 被引量:1

共引文献420

同被引文献140

引证文献22

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部